Michael Lauer, deputy director of the National Institutes of Health’s extramural research, will leave the agency at the end ...
Ruling on a lawsuit filed by 22 states, a federal judge has temporarily blocked the National Institutes of Health plan to cap ...
These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.
Attorneys general from 22 states had filed a lawsuit seeking to block the policy that would dramatically change NIH's grant-making by limiting how much it will disburse for overhead costs.
The fight unfolding over the Trump administration's sudden limit on NIH grant funding could slash budgets for Washington's ...
The memo, penned by NIH Deputy Director for Extramural Research Michael Lauer and NIH Chief Grants Officer Michelle Bulls, ...
The order was temporarily blocked after Massachusetts and 21 other states filed a lawsuit opposing the NIH funding cuts.
“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...